Reading GOCO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GOCO free→Reading GOCO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GOCO free→NASDAQFinancialsInsurance BrokersSnapshot 2026-06-15
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and management's recent track record has been unsteady, with frequent disruptive corporate changes. The company was unprofitable over the past year, so its earnings quality can't be assessed, and it has a capital-unfriendly stance. Risk is high, and the sector backdrop is a headwind, with performance compared to sector peers below typical. The read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 0 valuation methods, at three horizons. Current price $0.30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Not enough valuation methods to set a 12-month read yet.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Financials names rated weak grew net income 56% of the time over the next year (vs 59% for the rest of the cohort, n=3730).
Over the trailing year it converted 0.35x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
11 material management or governance events in the past 24 months, led by executive changes. Historically, Financials names rated volatile grew net income 54% of the time over the next year (vs 57% for the rest of the cohort, n=3774).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $-2.07 → $-1.58 (+23.6% / 30d). 1 raised, 1 cut, 3 covering analysts.
0 upgrades, 0 downgrades / 30d. 40% of analysts rate Buy.
0 positive, 3 negative / 30d. See F4 management tile for the event list.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$420.
How much price usually moves either way.
On a bad day, this stock has moved -$1,021.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $9,550.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Delisting could hurt GoHealth's chances to raise money and attract investors. This is important to watch.
Confirms:The company confirms it meets listing rules and avoids being delisted.
Disproves:The company is now officially off the exchange.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for GOCO yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Bankruptcy or Receivership On June 7, 2026 (the “Petition Date”), GoHealth, Inc. (the “Company”), GoHealth Holdings, LLC (“GoHealth Holdings”), and certain of their direct and indirect subsidiaries (collectively with the Company and GoHealth Holdings, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) under Chapter 11 of Title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Insurance Brokers.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
GOCO GoHealth, Inc. | Below typical Show detailsSector percentile: 3 of 100 | — | high |
MRSH Marsh McLennan | Above typical Show detailsSector percentile: 78 of 100 | full | moderate |
AON Aon plc | Above typical Show detailsSector percentile: 71 of 100 | full | moderate |
AJG Arthur J. Gallagher & Co. | Above typical Show detailsSector percentile: 75 of 100 | full | moderate |
WTW Willis Towers Watson | Typical Show detailsSector percentile: 38 of 100 | fair | moderate |
Not investment advice. As of 2026-06-15.
via XLF
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Engage in Chapter 11 restructuring to address financial obligations and stabilize operations.
Implement a Cash Performance Plan to incentivize the CEO's performance.
Why it matters: News on bankruptcy will help investors see the company's future and finances.
Confirms one read:The court approves a plan that helps GoHealth leave bankruptcy.
Confirms the other:The court rejects the restructuring plan or extends bankruptcy without a fix.
Why it matters: Progress in the restructuring process is key to GoHealth's financial recovery. Investors need to see if the plan is effective.
Confirms:Management says it has hit an important goal in the Chapter 11 process.
Disproves:No news or more delays in the restructuring timeline.
Why it matters: The Cash Performance Plan aims to align executive pay with company performance. Early results will show if this strategy is effective.
Confirms:The company reports better financial results from the CEO's Cash Performance Plan.
Disproves:Revenue keeps falling or no change in financial numbers despite the Cash Performance Plan.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed in the Current Report on Form 8-K filed by GoHealth, Inc. (the “Company”), on June 7, 2026, the Company, GoHealth Holdings, LLC (“GoHealth Holdings”) and certain of their direct and indirect subsidiaries (collectively with the Company and GoHealth Holdings, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) under Chapter 11 of Title 11 of the United States…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers . Cash Performance Award Agreement with Chief Executive Officer On June 5, 2026, the Company entered into a 2026 Cash Performance Plan Award Agreement (the “Award Agreement”) with Vijay Kotte, the Company’s Chief Executive Officer, pursuant to the GoHealth, Inc. 2026 Cash Performance Plan (the “Cash Performance Plan”), which is described below. Subj…
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement The filing of the Chapter 11 Cases constitutes an event of default under each of the following material debt agreements (together, the “Debt Agreements”): • Superpriority Senior Secured Credit Agreement, dated as of August 6, 2025 (the “Superpriority Credit Agreement”), by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders and issuing banks part…
Regulation FD Disclosure. Press Release On June 7, 2026, the Company issued a press release announcing the filing of the Chapter 11 Cases. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated herein by reference. Additional Information about the Chapter 11 Cases Additional information about the Chapter 11 Cases, including access to Bankruptcy Court documents, is available online at https://www.bankruptcy.angeio…